Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 心血管医学和血液学
  5. 心脏病 (包括心血管疾病)
  6. 三血管冠状动脉疾病的分流储备导向pci或冠状动脉绕道手术:fame 3试验的3年随访
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 心血管医学和血液学
  5. 心脏病 (包括心血管疾病)
  6. 三血管冠状动脉疾病的分流储备导向pci或冠状动脉绕道手术:fame 3试验的3年随访

相关实验视频

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K

三血管冠状动脉疾病的分流储备导向PCI或冠状动脉绕道手术:FAME 3试验的3年随访

Frederik M Zimmermann1, Victoria Y Ding2, Nico H J Pijls1

  • 1Catharina Hospital, Eindhoven, the Netherlands (F.M.Z., N.H.J.P., A.H.M.v.S., P.A.L.T.).

Circulation
|August 21, 2023

在PubMed 上查看摘要

概括
此摘要是机器生成的。

在患有三血管冠状动脉疾病的患者中,与冠状动脉旁路移植 (CABG) 相比,分流储备引导的皮肤冠状动脉干预 (PCI) 没有显示死亡,心脏病发作或中风的差异. 然而,PCI导致心脏病发作率更高.

关键词:
冠状动脉绕道药物释放的支架通过皮肤进行冠状动脉干预

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K

相关实验视频

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.0K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K

科学领域:

  • 心脏病学
  • 干预心脏病学
  • 临床试验

背景情况:

  • 之前的研究表明冠状动脉旁路移植 (CABG) 的死亡率,心肌梗塞 (MI) 或中风率低于多血管冠状动脉疾病的穿皮冠状动脉干预 (PCI).
  • 较早的研究没有经常使用当前一代的药物释放支架或分流储备 (FFR) 来指导PCI,这可能会影响结果.

研究的目的:

  • 在不涉及左主动脉的三血管冠状动脉疾病患者中,比较FFR引导的PCI与CABG之间的3年死亡,MI或中风发生率.

主要方法:

  • 在FAME 3试验中,有1500名患有三血管冠状动脉疾病的患者随机接受了FFR指导的PCI,使用佐托利斯释放药物支架或CABG.
  • 在这两组患者中,超过96%的患者得到了随访.

主要成果:

  • 在FFR指导PCI和CABG之间,3年后死亡,心脏病发作或中风的综合情况没有显著差异 (12. 0%与9. 2%;P=0. 07).
  • 这两组的死亡率和中风率相似.
  • 肌肉梗塞在PCI后发生的频率比CABG更高 (7. 0%对比4. 2%;P=0. 02).

结论:

  • 在3年的随访期内,使用当前一代药物释放支架进行的FFR导向PCI显示死亡率,心脏病发作率或中风率与CABG相似.
  • 在PCI后观察到心脏病发病率较高,死亡率和中风率相似.
  • 这些发现支持三血管冠状动脉疾病患者的共同决策.